Company intelligence / Profile preview

Xnerve Medical

Plano, Texas, USA

Ownership: Private
Development stage: Other

Overview

The company’s next-gen wireless vagus nerve stimulator showed robust safety and efficacy in two phase 2 randomized controlled trials completed in 2024, with substantial data supporting both improved neurological outcomes and reduced adverse events compared to conventional stimulators

Therapeutic areas: NeurologyPsychiatry
Modalities: DeviceNeuromodulation implant
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with Texas Biomedical Device Center and multiple clinical centers involved in spouse clinical device testing

Beyond the preview

Go deeper on Xnerve Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xnerve Medical.

Explore the full profile